Technical Analysis for AMRX - Amneal Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 4.94 -0.20% -0.01
AMRX closed up 1.85 percent on Wednesday, July 28, 2021, on 62 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Aug 4
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical AMRX trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction -0.20%
Stochastic Reached Overbought Strength -0.20%
Weak + Overbought Other -0.20%
Overbought Stochastic Strength -0.20%
20 DMA Support Bullish 1.65%
Calm After Storm Range Contraction 1.65%
Crossed Above 20 DMA Bullish 2.28%
Calm After Storm Range Contraction 2.28%
NR7 Range Contraction 2.28%
NR7-2 Range Contraction 2.28%
Older End-of-Day Signals for AMRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 3 hours ago
60 Minute Opening Range Breakdown about 6 hours ago
Rose Above Previous Day's High about 7 hours ago
Up 2% about 7 hours ago
Up 1% about 7 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Amneal Pharmaceuticals, Inc. Description

Amneal Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It operates in two segments, which include Impax Generics and Impax Specialty Pharma. The Impax Generics is focused on the development, manufacture, sale and distribution of the Company's generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their drug names. The Impax Specialty Pharma is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease (PD), post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Industry Pharmaceutical Drugs Health Sciences Pharmaceutical Products Parkinson's Disease Drug Product Treatment Of Parkinson's Disease Migraine Drug Products Headache Treatment Of Migraine Carbidopa Generic Drug Headaches L Dopa Migraine Headache Generic Products Migraine Headaches Pharmaceutical Product Zolmitriptan

Is AMRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.44
52 Week Low 3.45
Average Volume 779,216
200-Day Moving Average 5.20
50-Day Moving Average 5.26
20-Day Moving Average 4.79
10-Day Moving Average 4.67
Average True Range 0.21
ADX 24.42
+DI 26.02
-DI 28.01
Chandelier Exit (Long, 3 ATRs) 4.77
Chandelier Exit (Short, 3 ATRs) 4.63
Upper Bollinger Bands 5.32
Lower Bollinger Band 4.25
Percent B (%b) 0.65
BandWidth 22.25
MACD Line -0.13
MACD Signal Line -0.19
MACD Histogram 0.0657
Fundamentals Value
Market Cap 730.76 Million
Num Shares 148 Million
EPS 0.42
Price-to-Earnings (P/E) Ratio 11.84
Price-to-Sales 0.32
Price-to-Book 2.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.17
Resistance 3 (R3) 5.16 5.08 5.13
Resistance 2 (R2) 5.08 5.03 5.09 5.12
Resistance 1 (R1) 5.02 4.99 5.05 5.02 5.11
Pivot Point 4.94 4.94 4.96 4.94 4.94
Support 1 (S1) 4.87 4.88 4.91 4.88 4.79
Support 2 (S2) 4.79 4.85 4.80 4.78
Support 3 (S3) 4.73 4.79 4.77
Support 4 (S4) 4.73